Phase 2 Study of Pemetrexed in Combination With Cisplatin and Cetuximab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase of Trial: Phase II
Latest Information Update: 23 Mar 2016
At a glance
- Drugs Pemetrexed (Primary) ; Cetuximab; Cisplatin; Cisplatin cholylglycinate
- Indications Head and neck cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 18 Oct 2012 Planned End Date changed from 1 Dec 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 02 Aug 2012 Planned End Date changed from 1 Jul 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 22 Mar 2012 Planned end date changed from 1 Apr 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.